Role of Nitric Oxide in Modulating the Vasoconstrictor Actions of Angiotensin II in Preglomerular and Postglomerular Vessels in Dogs
- 1 December 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 26 (6) , 1024-1029
- https://doi.org/10.1161/01.hyp.26.6.1024
Abstract
Abstract The purpose of this study was to determine the role of nitric oxide in modulating the vasoconstrictor effect of angiotensin II (Ang II) on renal segmental resistances in the dog. To achieve this objective we examined the effect of intrarenal infusions of Ang II on preglomerular and postglomerular resistances in the presence and absence of intrarenal nitric oxide synthesis inhibition established by an intrarenal infusion of N G -nitro- l -arginine-methyl ester at 5 μg/kg per minute in dogs. The whole-kidney stop-flow technique was used. Renal artery pressure was servo-controlled at 78±2 mm Hg throughout the study. Intrarenal infusion of Ang II alone at 0.5 and 2.0 ng/kg per minute increased renal vascular resistance (Δ0.064±0.011 and Δ0.171±0.030 mm Hg/mL per minute, respectively) and decreased renal blood flow (Δ21±4 and Δ45±9 mL/min). Associated with these changes, glomerular hydrostatic pressure and preglomerular resistance increased slightly (Δ1.1±0.9 and Δ1.6±1.8 mm Hg; Δ0.008±0.005 and Δ0.030±0.010 mm Hg/mL per minute, respectively), and postglomerular resistance increased markedly (Δ0.046±0.011 and Δ0.116±0.026 mm Hg/mL per minute). When dogs were pretreated with an intrarenal infusion of the nitric oxide synthesis blocker, Ang II at 0.5 and 2.0 ng/kg per minute increased renal vascular resistance (Δ0.271±0.058 and Δ1.088±0.242 mm Hg/mL per minute) and decreased renal blood flow (Δ28±5 and Δ62±9 mL/min). However, in sharp contrast to vehicle pretreatment, Ang II decreased glomerular hydrostatic pressure (Δ3.4±1.5 and Δ9.9±2.0 mm Hg), increased postglomerular resistance (Δ0.122±0.029 and Δ0.439±0.133 mm Hg/mL per minute), and increased preglomerular resistance (Δ0.109±0.031 and Δ0.487±0.099 mm Hg/mL per minute) in dogs pretreated with the nitric oxide synthesis inhibitor. In summary, these data indicate that during vehicle treatment Ang II infusion in the stop-flow kidney had a predominant effect on postglomerular resistance. However, when nitric oxide synthesis was blocked, Ang II had a profound effect on preglomerular resistance. These findings suggest that nitric oxide may play an important role in protecting mainly preglomerular vessels and to a lesser extent postglomerular vessels from Ang II–induced renal vasoconstriction in dogs.Keywords
This publication has 10 references indexed in Scilit:
- Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.Journal of Clinical Investigation, 1993
- EDRF modulates renal hemodynamics during unilateral ureteral obstruction in the ratKidney International, 1992
- Control of Renal Hemodynamics During Intrarenal and Systemic Blockade of Nitric Oxide Synthesis in Conscious DogsJournal of Cardiovascular Pharmacology, 1992
- Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.Journal of Clinical Investigation, 1991
- Endothelium-derived relaxing and contracting factors: Perspectives in nephrologyKidney International, 1991
- Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG IIAmerican Journal of Physiology-Renal Physiology, 1989
- Interaction between renal prostaglandins and angiotensin II in controlling glomerular filtration in the dogClinical Science, 1987
- Long-term Efficacy of Screening for Hypertension in a CommunityJournal Of Hypertension, 1985
- Contribution of the renin-angiotensin system to the control of intrarenal hemodynamicsKidney International, 1984
- Tubular pressure gradients and filtration dynamics during urinary stop flow in the ratPflügers Archiv - European Journal of Physiology, 1965